B01=Aron K. Barbey
B01=Barbara J. Sahakian
B01=Gregory J. Boyle
About
Professor Boyle has spent over three decades undertaking quantitative research in the field of psychometrics, as related to the measurement of individual differences in
personality, intelligence, and motivation, as well as undertaking studies within the fields of neuropsychology, clinical psychology, and educational psychology. In more recent years, he has applied his extensive research skills to studies within the broad fields of medical/health psychology, and has undertaken many studies within the
area of women′s health. Lately, he has focused his attention more on research topics pertaining to men′s health. Georg Northoff is Canada Research Chair for Mind, Brain Imaging and Neuroethics at the University of Ottawa/Canada. He made major contribution in neuroscience on the neural correlates of mental features like consciousness, self, mind wandering and mental disorders having discovered their spatiotemporal mechanisms bridging the gap of neural and mental activity. This led him to develop an integrated brain-mind model for which Spatiotemporal Neuroscience is the key discipline.
Aron K. Barbey is Professor of Psychology, Neuroscience, and Bioengineering at the University of Illinois at Urbana-Champaign. He is chair of the Intelligent Systems Research Theme, leader of the Intelligence, Learning, and Plasticity Initiative, and director of the Decision Neuroscience Laboratory at the Beckman Institute for Advanced Science and Technology. Dr. Barbey’s research investigates the neural mechanisms of human intelligence and decision making, with particular emphasis on enhancing these functions through cognitive neuroscience, physical fitness, and nutritional intervention. His research has been supported by the Office of the Director of National Intelligence, the Department of Defense, the White House BRAIN Initiative, the National Institutes of Health, the National Science Foundation, and private industry (Abbott Nutrition, Google Brain, and PepsiCo). Dr. Barbey has received multiple research awards and is editor of the Cambridge Handbook of Intelligence and Cognitive Neuroscience and the forthcoming Oxford Handbook of Cognitive Enhancement and Brain Plasticity. He earned his doctorate in Psychology from Emory University and completed a research fellowship in Cognitive Neuroscience at the National Institutes of Health.
Felipe Fregni, MD, PhD, MMSc, MPH is the director of Spaulding Neuromodulation Center. He is an Associate Professor of PM&R at Harvard Medical School and an Associate Professor of Epidemiology. He is also the course director for the HMS continuing medical education course, Principles and Practice of Clinical Research, a 6-month distance learning course. It focuses on promoting collaboration and bringing clinical research education to practicing clinicians worldwide. Currently, his research is focused on understanding neuroplastic changes associated with conditions such as chronic pain, Parkinson’s disease, and stroke, using non-invasive brain stimulation as an investigative tool for such aims. In addition, his laboratory is comprised of about 15 research fellows and staff, and is a trai ning center for clinical research and neuromodulation methodology. Dr. Fregni’s laboratory is funded by several sponsors including NIH, the Christopher and Dana Reeve Foundation, CIMIT, and the RJG Foundation.
Barbara J Sahakian is Professor of Clinical Neuropsychology at the University of Cambridge Department of Psychiatry and Behavioural and Clinical Neuroscience Institute. She is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital, Cambridge. She holds a PhD and a DSc from the University of Cambridge. She is a Fellow of the Academy of Medical Sciences and was President of the International Neuroethics Society (2014-2016) and the British Association for Psychopharmacology (2012-2014). In 2016, she was recipient of the Robert Sommer Award and the International College of Neuropsychopharmacology (CINP) Ethics Prize. Sahakian is also a Member of the International Expert Jury for the 2017 Else Kröner-Fresenius-Stiftung Prize dedicated to the biological basis of psychiatric disorders. She is co-author of ‘Bad Moves: How decision making goes wrong and the ethics of smart drugs’ (Oxford University Press, 2013) and of ‘Sex, Lies and Brain Scans. How fMRI reveals what really goes on in our minds’ (OUP, 2017). She is co-editor of The Oxford Handbook of Neuroethics (OUP, 2011) and Translational Neuropsychopharmacology (Current Topics in Behavioral Neurosciences) (Springer International Publishing, 2016).
Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. She is perhaps best known for her work on ‘hot’ and ‘cold’ cognitive deficits in depression and early detection and early treatment with cholinesterase inhibitors in Alzheimer’s disease. She has over 400 publications in high impact scientific journals. Sahakian co-invented the neuropsychological CANTAB tests. Sahakian has contributed to Neuroscience and Mental Health Government Policy and has spoken on resilience, brain health, neuroscience and mental health at the World Economic Forum, Davos, 2014. She is a member of the World Economic Forum Global Agenda Council on Brain Research.
